Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 1999. Start Trial.
Date Value
October 28, 2026 586.48
October 27, 2026 591.20
October 26, 2026 592.84
October 23, 2026 587.50
October 22, 2026 584.79
October 21, 2026 563.49
October 20, 2026 553.88
October 19, 2026 543.15
October 16, 2026 533.12
October 15, 2026 541.51
October 14, 2026 540.03
October 13, 2026 543.40
October 12, 2026 550.10
October 09, 2026 549.16
October 08, 2026 532.78
October 07, 2026 545.00
October 06, 2026 541.62
October 05, 2026 536.40
October 02, 2026 541.70
October 01, 2026 571.38
September 30, 2026 541.89
September 29, 2026 481.47
September 28, 2026 485.54
September 25, 2026 475.45
September 24, 2026 472.21
Date Value
September 23, 2026 489.42
September 22, 2026 497.59
September 21, 2026 493.10
September 18, 2026 494.63
September 17, 2026 497.27
September 16, 2026 498.48
September 15, 2026 500.35
September 14, 2026 502.70
September 11, 2026 497.11
September 10, 2026 503.86
September 09, 2026 506.82
September 08, 2026 497.97
September 04, 2026 487.61
September 03, 2026 490.24
September 02, 2026 492.02
September 01, 2026 512.70
August 31, 2026 510.38
August 28, 2026 515.46
August 27, 2026 527.91
August 26, 2026 516.68
August 25, 2026 518.53
August 24, 2026 512.88
August 21, 2026 513.12
August 20, 2026 521.00
August 19, 2026 529.14

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Liquidia Corp. 45.72
MannKind Corp. 3.43
Gilead Sciences, Inc. 233.32
Insmed, Inc. 96.98
Alnylam Pharmaceuticals, Inc. 232.40